Cargando…
Amylase α-2A Autoantibodies: Novel Marker of Autoimmune Pancreatitis and Fulminant Type 1 Diabetes
OBJECTIVE— The pathogenesis of autoimmune pancreatitis (AIP) and fulminant type 1 diabetes remains unclear, although it is known that immune-mediated processes severely compromise the endocrine and exocrine functions in both diseases. RESEARCH DESIGN AND METHODS— We have screened a λTriplEx2 human p...
Autores principales: | Endo, Toyoshi, Takizawa, Soichi, Tanaka, Shoichiro, Takahashi, Masashi, Fujii, Hideki, Kamisawa, Terumi, Kobayashi, Tetsuro |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646073/ https://www.ncbi.nlm.nih.gov/pubmed/19001184 http://dx.doi.org/10.2337/db08-0493 |
Ejemplares similares
-
RIG-I– and MDA5-Initiated Innate Immunity Linked With Adaptive Immunity Accelerates β-Cell Death in Fulminant Type 1 Diabetes
por: Aida, Kaoru, et al.
Publicado: (2011) -
Increase in Pancreatic Proinsulin and Preservation of β-Cell Mass in Autoantibody-Positive Donors Prior to Type 1 Diabetes Onset
por: Rodriguez-Calvo, Teresa, et al.
Publicado: (2017) -
GAD65 Autoantibody Responses in Japanese Latent Autoimmune Diabetes in Adult Patients
por: Maruyama, Taro, et al.
Publicado: (2008) -
Enterovirus Infection, CXC Chemokine Ligand 10 (CXCL10), and CXCR3 Circuit: A Mechanism of Accelerated β-Cell Failure in Fulminant Type 1 Diabetes
por: Tanaka, Shoichiro, et al.
Publicado: (2009) -
Treatment of Autoimmune Pancreatitis with the Anecdotes of the First Report
por: Kamisawa, Terumi, et al.
Publicado: (2012)